GPT-Rosalind: OpenAI's Life Sciences AI Upgrade (2026)
June 5, 2026
OpenAI's June 2026 GPT-Rosalind update beats GPT-5.5 on drug-discovery benchmarks while using fewer tokens, adds Codex plugins, and partners with Novo Nordisk.
OpenAI's June 2026 GPT-Rosalind update beats GPT-5.5 on drug-discovery benchmarks while using fewer tokens, adds Codex plugins, and partners with Novo Nordisk.
OpenAI's GPT-Rosalind is its first frontier model built for drug discovery, biology, and translational medicine. Benchmarks, partners, and access details.